Citation
Donaldson, Matthew R., et al. "Correlation of Duodenal Histology With Tissue Transglutaminase and Endomysial Antibody Levels in Pediatric Celiac Disease." Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association, vol. 5, no. 5, 2007, pp. 567-73.
Donaldson MR, Firth SD, Wimpee H, et al. Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clin Gastroenterol Hepatol. 2007;5(5):567-73.
Donaldson, M. R., Firth, S. D., Wimpee, H., Leiferman, K. M., Zone, J. J., Horsley, W., O'Gorman, M. A., Jackson, W. D., Neuhausen, S. L., Hull, C. M., & Book, L. S. (2007). Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association, 5(5), 567-73.
Donaldson MR, et al. Correlation of Duodenal Histology With Tissue Transglutaminase and Endomysial Antibody Levels in Pediatric Celiac Disease. Clin Gastroenterol Hepatol. 2007;5(5):567-73. PubMed PMID: 17428743.
TY - JOUR
T1 - Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease.
AU - Donaldson,Matthew R,
AU - Firth,Sean D,
AU - Wimpee,Holly,
AU - Leiferman,Kristin M,
AU - Zone,John J,
AU - Horsley,Wyatt,
AU - O'Gorman,Molly A,
AU - Jackson,W Daniel,
AU - Neuhausen,Susan L,
AU - Hull,Christopher M,
AU - Book,Linda S,
Y1 - 2007/04/11/
PY - 2007/4/13/pubmed
PY - 2007/12/14/medline
PY - 2007/4/13/entrez
SP - 567
EP - 73
JF - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
JO - Clin Gastroenterol Hepatol
VL - 5
IS - 5
N2 - BACKGROUND & AIMS: IgA antibodies against tissue transglutaminase (TTGA) and endomysium (EMA) are sensitive and specific markers for celiac disease (CD). Data correlating TTGA and EMA levels with degree of villous atrophy are limited. We compared duodenal histopathology in pediatric CD patients with TTGA and EMA serologies, symptoms, height, and weight. METHODS: We identified 117 pediatric patients retrospectively who had serologic testing for IgA TTGA and IgA EMA and duodenal biopsies graded by modified Marsh criteria as 0-3c. Data were analyzed with Spearman rank correlation and multinomial logistic regression. RESULTS: IgA TTGA (r = .704, P < .001) and IgA EMA (r = 0.740, P < .001) correlated with intestinal villous atrophy in pediatric CD patients by Spearman rank correlation. Similar correlations were found in a subset of 23 patients younger than 3 years of age. Multinomial logistic regression revealed increased probability of Marsh 3a or greater changes with increasing TTGA or EMA levels. Strongly positive antibody levels (TTGA >100 units or EMA titer >1:1280) were highly specific (>98%) for Marsh 3a or greater lesions. Among symptoms, abdominal distention and diarrhea were associated with abnormal histology. CONCLUSIONS: IgA TTGA and EMA levels correlate with duodenal villous atrophy in pediatric CD patients. IgA TTGA >100 or EMA >1:1280 were nearly always associated with CD histopathology. With further validation of this observation, strongly positive titers might be considered sufficient for diagnosis of pediatric patients at risk for CD. Symptoms, height, and weight are not reliable predictors of CD.
SN - 1542-7714
UR - https://www.unboundmedicine.com/medline/citation/17428743/Correlation_of_duodenal_histology_with_tissue_transglutaminase_and_endomysial_antibody_levels_in_pediatric_celiac_disease_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S1542-3565(07)00061-4
DB - PRIME
DP - Unbound Medicine
ER -